FDA Submissions for Interoperable Medical Devices – Comment Period Extended for Draft Guidance

February 24, 2016

Additional information on FDA’s recommendations for interoperable medical devices is available in our blog post entitled “A Closer Look at FDA’s Draft Guidance Regarding Premarket Submissions for Interoperable Medical Devices.”

On January 26, 2016, the FDA published a draft guidance entitledDesign Considerations and Pre-market Submission Recommendations for Interoperable Medical Devices.”  The document provides medical device manufacturers with assistance regarding product design and labeling of interoperable devices.

Interoperable medical devices are two or more devices that exchange data and information in a safe and effective manner. The ability to do this is a growing need within the healthcare industry, which is what drove the FDA to develop this draft guidance.

When the draft guidance was released in late January, the FDA asked interested persons to submit comments and suggestions by March 28, 2016. In response to a number of requests for an extension, on February 23rd, the FDA announced that the comment period will remain open for an additional 30 days. As such, interested persons should submit comments, questions, and/or concerns by April 28, 2016.

Do you manufacture a medical device or any other type of FDA-regulated product? We can help ensure that your product is compliant with all requirements. For additional information on how we can help you, contact us today.

Agency Alerts General Regulatory

February 11, 2016

Display Devices for Diagnostic Radiology, Part 1: Describing Display Devices in 510(k) Submissions

On February 9, 2016, the FDA published a draft guidance entitled “Display Devices for Diagnostic Radiology.” The document, which will replace a 2008 guidance (“Display Accessories for Full-Field...

Read the Full Article
Agency Alerts General Regulatory

February 16, 2016

Display Devices for Diagnostic Radiology, Part 2: FDA Labeling Requirements for 510(k) Submissions

Last week, we provided you with details on FDA’s recommendations for describing display devices in 510(k) premarket submissions. Did we leave you wanting more? Well if you were wishing for additional...

Read the Full Article
Agency Alerts General Regulatory

March 24, 2018

FDA Issues Final Rule to Delay Implementing Parts of ‘Intended Use’ Regulation

On Friday, March 16th, the FDA published a notice in the Federal Register, stating that the effective date for the amendments related to intended use would be delayed indefinitely. In the notice, the...

Read the Full Article